IMMUNE CHECKPOINT INHIBITOR SALVAGE THERAPY IN PATIENT WITH REFRACTORY PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA. (2019). Voprosy Onkologii, 65(2), 294-297. https://doi.org/10.37469/0507-3758-2019-65-2-294-297